NMN Clinical tRiaLisT Fellowship 2025
Theranostics are emerging as novel treatment paradigm in Neuro-Oncology, but specific challenges need to be considered for clinical trials with radioligand therapies. The NMN Clinical tRiaLisT Fellowship offers training and hands-on experience in clinical trial development for theranostic treatments in CNS tumors under the supervision of Prof. Dr. Nathalie Albert (Nuclear Medicine) and Prof. Dr. Matthias Preusser (Medical Oncology).
Fellowship content:
- One year fellowship at LMU Munich with training modules at Medical University of Vienna
- Clinical trial methodology and conduct:
- Study design, endpoints, statistics, legal, ethics, project management
- Medical writing
- Presentation skills
- Research project:
- Clinical trial protocol development
- Collection of supportive data in a companion project
- Peer-reviewed publication
Amount and duration:
- One fellow receives a total of €50,000 for a one-year fellowship duration
Application requirements:
- Applicants should be engaged in clinical research in the field of Nuclear Medicine or Neuro-Oncology
- Applicants should be proficient in English
Selection process:
- Applicants are invited to send a motivation letter (max. 2 pages), CV (max. 3 pages), publication list, and a support letter from the home institute signed by the applicant’s department head (max. 2 pages) to by July 31st 2025
- Documents should be provided in English
- The two-step selection is based on the application documents and an interview by the NMN Clinical tRiaLisT Fellowship program heads
This program is supported by a grant by Telix.
